This contradicts other previous studies, including three models of cisplatin-induced acute kidney injury [22, 26, 37], a model of hepatorenal syndrome [47], and a rat model of IRI [46], which demonstrated the reduction of blood urea nitrogen and serum creatinine by CB2 agonists. The gene discussed is CNR2; the disease is liver disorder.